Experts in producing high-quality APIs from natural sources, specializing in advanced extraction and isolation techniques.
Reset all filters
01 1Phytex Australia Pty Ltd
Reset all filters
01 1AL Pharma Co., Ltd.
Reset all filters
01 1Scopolamine
Reset all filters
01 1Australia
Experts in producing high-quality APIs from natural sources, specializing in advanced extraction and isolation techniques.
Registrant Name : AL Pharma Co., Ltd.
Registration Date : 2022-05-06
Registration Number : 20220506-211-J-1287
Manufacturer Name : Phytex Australia Pty Ltd
Manufacturer Address : 6 Norman Street Peakhurst NSW 2210 Australia
A Scopolamine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Scopolamine, including repackagers and relabelers. The FDA regulates Scopolamine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Scopolamine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Scopolamine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Scopolamine supplier is an individual or a company that provides Scopolamine active pharmaceutical ingredient (API) or Scopolamine finished formulations upon request. The Scopolamine suppliers may include Scopolamine API manufacturers, exporters, distributors and traders.
click here to find a list of Scopolamine suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Scopolamine Drug Master File in Korea (Scopolamine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Scopolamine. The MFDS reviews the Scopolamine KDMF as part of the drug registration process and uses the information provided in the Scopolamine KDMF to evaluate the safety and efficacy of the drug.
After submitting a Scopolamine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Scopolamine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Scopolamine suppliers with KDMF on PharmaCompass.
We have 1 companies offering Scopolamine
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?